↓ Skip to main content

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

Overview of attention for article published in JAMA Oncology, April 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
8 news outlets
policy
1 policy source
twitter
160 X users
facebook
3 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
442 Dimensions

Readers on

mendeley
289 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
Published in
JAMA Oncology, April 2019
DOI 10.1001/jamaoncol.2018.5801
Pubmed ID
Authors

Wassim Abida, Michael L. Cheng, Joshua Armenia, Sumit Middha, Karen A. Autio, Hebert Alberto Vargas, Dana Rathkopf, Michael J. Morris, Daniel C. Danila, Susan F. Slovin, Emily Carbone, Ethan S. Barnett, Melanie Hullings, Jaclyn F. Hechtman, Ahmet Zehir, Jinru Shia, Philip Jonsson, Zsofia K. Stadler, Preethi Srinivasan, Vincent P. Laudone, Victor Reuter, Jedd D. Wolchok, Nicholas D. Socci, Barry S. Taylor, Michael F. Berger, Philip W. Kantoff, Charles L. Sawyers, Nikolaus Schultz, David B. Solit, Anuradha Gopalan, Howard I. Scher

X Demographics

X Demographics

The data shown below were collected from the profiles of 160 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 289 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 289 100%

Demographic breakdown

Readers by professional status Count As %
Other 38 13%
Researcher 37 13%
Student > Ph. D. Student 31 11%
Student > Master 20 7%
Student > Bachelor 20 7%
Other 42 15%
Unknown 101 35%
Readers by discipline Count As %
Medicine and Dentistry 89 31%
Biochemistry, Genetics and Molecular Biology 43 15%
Agricultural and Biological Sciences 13 4%
Immunology and Microbiology 8 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 2%
Other 25 9%
Unknown 106 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 148. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2021.
All research outputs
#277,216
of 25,385,509 outputs
Outputs from JAMA Oncology
#459
of 3,308 outputs
Outputs of similar age
#5,924
of 366,624 outputs
Outputs of similar age from JAMA Oncology
#12
of 101 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.4. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,624 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.